DNA topoisomerase II as the cellular target of a novel antitumor agent ICRF-193, a bisdioxopiperazine derivative, in Xenopus egg extract

Biochemical and Biophysical Research Communications

Volumn 235, Issue 3, 1997, Pages 571-575

  Sato, Makoto ^a   Ishida, Ryoji ^c   Ohsumi, Keita ^b   Narita, Toshiharu ^a   Andoh, Toshiwo ^c  

^a ZENYAKU KOGYO CO LTD   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

2,3 BIS(3,5 DIOXO 1 PIPERAZINYL)BUTANE; ANTINEOPLASTIC AGENT; DNA TOPOISOMERASE (ATP HYDROLYSING); MONOCLONAL ANTIBODY; PIPERAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CATTLE; CHROMATIN; CHROMOSOME CONDENSATION; DRUG TARGETING; METAPHASE CHROMOSOME; NONHUMAN; OOCYTE; PRIORITY JOURNAL; SPERMATOZOON; THYMUS; XENOPUS;

ANIMALIA; BOS TAURUS;

EID: 0031587947     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.6851     Document Type: Article

References (35)

1. Wang J. C. Annu. Rev. Biochem. 65:1996;635-692.
2. Watt P. M., Hickson I. D. Biochem. J. 303:1994;681-695.
3. Holm C., Goto T., Wang J. C., Botstein D. Cell. 41:1985;553-563.
4. Uemura T., Ohkura H., Adachi Y., Morino K., Shiozaki K., Yanagida M. Cell. 50:1987;917-925.
5. Wood E. R., Earnshaw W. C. J. Cell Biol. 111:1990;2839-2850.
6. Adachi Y., Luke M., Laemmli U. K. Cell. 64:1991;137-148.
7. Hirano T., Mitchison T. J. J. Cell Biol. 120:1993;601-612.
8. Shamu C. E., Murray A. W. J. Cell Biol. 117:1992;921-934.
9. Newport J., Spann T. Cell. 48:1987;219-230.
10. Downes C. S., Mullinger A. M., Johnson R. T. Proc. Natl. Acad. Sci. USA. 88:1991;8895-8899.
11. Ishida R., Sato M., Narita T., Utsumi K. R., Nishimoto T., Morita T., Nagata H., Andoh T. J. Cell Biol. 126:1994;1341-1351.
12. Creighton A. M., Hellman K., Whitecross S. Nature (Lond.). 222:1969;384-385.
13. Hellman K., Burrage K. Nature (Lond.). 224:1969;273-275.
14. Hellman E. H., Witiak D. T., Hellman K., Waravdekar V. S. Adv. Pharmacol. Chemother. 19:1982;249-290.
15. Tanabe K., Ikegami Y., Ishida R., Andoh T. Cancer Res. 51:1991;4903-4908.
16. Ishida R., Miki T., Narita T., Yui R., Sato M., Utsumi K. R., Tanabe K., Andoh T. Cancer Res. 51:1991;4909-4916.
17. Ishimi Y., Ishida R., Andoh T. Mol. Cell. Biol. 12:1992;4007-4014.
18. Ishimi Y., Ishida R., Andoh T. J. Mol. Biol. 247:1995;835-839.
19. Ishida R., Hamatake M., Wasserman R. A., Nitiss J. L., Wang J. C., Andoh T. Cancer Res. 55:1995;2299-2303.
20. Halligan B. D., Edwards K. A., Liu L. F. J. Biol. Chem. 260:1985;2475-2482.
21. Murray A. W., Solomon M. J., Kirshner M. W. Nature (Lond.). 339:1989;280-286.
22. Liu L. F., Davis J. L., Calender R. Nucleic. Acids Res. 9:1981;3979-3989.
23. Harlow E., Lane D. Antibodies. 1988;Cold Spring Harbor Laboratory, Cold Spring Harbor.
24. Philpott A., Leno G. H. Cell. 69:1992;759-767.
25. Ohsumi K., Katagiri C. Dev. Biol. 148:1991;295-305.
26. Philpott A., Leno G. H., Laskey R. A. Cell. 65:1991;569-578.
27. Roca J., Ishida R., Berger J. M., Andoh T., Wang J. C. Proc. Natl. Acad. Sci. USA. 91:1994;1781-1785.
28. Narita T., Yaguchi S., Komatsu T., Takase M., Hoshino A., Inaba M., Tsukagoshi S. Cancer Chemother. Pharmacol. 26:1990;193-197.
29. Narita T., Koide Y., Yaguchi S., Kimula S., Izumisawa Y., Takase M., Inaba M., Tsukagoshi S. Cancer Chemother. Pharmacol. 28:1991;235-240.
30. Chen A. Y., Liu L. F. Annu. Rev. Pharmacol. Toxicol. 34:1994;191-218.
31. Lohka M. J., Masui Y. Science. 220:1983;719-721.
32. Dasso M., Newport J. W. Cell. 61:1990;811-823.
33. Hirano T., Mitchison T. J. J. Cell Biol. 115:1991;1479-1489.
34. Takasuga Y., Andoh T., Yamashita J., Yagura T. Exp. Cell Res. 217:1995;378-384.
35. Sato M., Ishida R., Narita T., Kato J.-I., Ikeda H., Fukasawa H., Andoh T. Biochem. Pharmacol. 1997.